BMC CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2021-09-15 丸仔

一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了

87 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2022-01-21 李明胤1234

慢死了慢死了慢死了，quality check卡了好久好久了，都没动过

529 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2024-01-22 水逆退散～来自广西

偏重的研究方向：乳腺癌
经验分享：1月14日至今扔在技术审核

30 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2022-04-26 ms4000000699988821

今日修回，如果接受回来分享经验

406 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2021-06-02 ms1000000930252947

你们quality check in progress 持续了多久了，我都好几天了还是这个状态

76 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2022-08-25 小白先生

BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！

123 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2021-02-20 Guo师傅

偏重的研究方向：肝癌
经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果

123 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2022-07-04 ms5000000604971836

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？

321 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2023-03-13 小余666 来自黑龙江省

偏重的研究方向：乳腺癌;Cancer
经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！

45 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051582, encodeId=f5a3105158230, content=一审返修回去，过了一个月跟我说责编罢工了，他们要重新安排编辑，又过了一个月编辑还没找到。太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f582156245, createdName=丸仔, createdTime=Wed Sep 15 19:36:52 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186853, encodeId=639c118685342, content=慢死了慢死了慢死了，quality check卡了好久好久了，都没动过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Fri Jan 21 15:50:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183220, encodeId=a47a218322048, content=偏重的研究方向：乳腺癌 经验分享：1月14日至今扔在技术审核, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Mon Jan 22 15:02:21 CST 2024, time=2024-01-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214891, encodeId=a4181214891e0, content=今日修回，如果接受回来分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Tue Apr 26 22:23:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970383, encodeId=aa449e03834f, content=你们quality check in progress 持续了多久了，我都好几天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Wed Jun 02 17:41:33 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240882, encodeId=dd5112408823e, content=BMC 全系列纯生信应该都不收了，试了三四个期刊，拒稿理由都是不接受未经实验验证的纯组学文章，经供大家参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Thu Aug 25 10:18:33 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925862, encodeId=aefa925862ae, content=偏重的研究方向：肝癌 经验分享：快一个月， ‘1 Reviewer report received’ ，不知道需要几个审稿人，也不知道啥时候才能一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=419a5461523, createdName=Guo师傅, createdTime=Sat Feb 20 16:30:52 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230426, encodeId=42d2123042632, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：大家有遇到邀请了好几波审稿人，都没人愿意审稿的情况吗？我的从最开始的5个、9个、17个到现在的24个审稿人，一个多月了，都没人愿意审稿，是不是我的文章太垃圾，别人不愿意审？连续邀请不到审稿人是不是会直接被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f48192464, createdName=ms5000000604971836, createdTime=Mon Jul 04 10:35:07 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119282, encodeId=2aaa2119282b2, content=偏重的研究方向：乳腺癌;Cancer 经验分享：修回两个月了，还是一个审稿人意见回来了！这是什么情况啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0dc85206623, createdName=小余666, createdTime=Mon Mar 13 23:21:57 CST 2023, time=2023-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1016883, encodeId=1785101688310, content=这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8d294915, createdName=阳帆远航, createdTime=Sun Sep 12 23:10:07 CST 2021, time=2021-09-12, status=1, ipAttribution=)]

2021-09-12 阳帆远航

这个垃圾杂志，投稿历经大修小修语言润色，花了5个多月，最后等来了拒稿，给出的理由是because your manuscript falls outside the aims and scope of this journal，外加一句Thank you for your patience。简直无底线，大家都尽量远离，版面费很贵，速度很墨迹，误人子弟。

49 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务